390
Breyer, J., dissenting
get "competitively priced compounded drugs as efficiently as possble").
Regardless, we here consider a facial attack on the statute. The respondents here focus their attack almost entirely upon consumer-directed advertising. They have not fully addressed separate questions involving the effect of advertising restrictions on information received by physicians. I would consequently leave these questions in abeyance. Considering the statute only insofar as it applies to advertising directed at consumers, I would hold it constitutional.
For these reasons, I dissent.
Page: Index Previous 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34Last modified: October 4, 2007